D-0661-2020 Class II Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-0661-2020 was initiated by AVKARE Inc. on Jan 7, 2020 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: High out of specification results for related compounds. The recall status is terminated (terminated Jul 14, 2021). Affected quantity: 3,989 cartons.

Recall details

Product Type
Drugs
Report Date
Jan 22, 2020
Initiation Date
Jan 7, 2020
Termination Date
Jul 14, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,989 cartons

Product description

Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.

Reason for recall

Failed Impurities/Degradation Specifications: High out of specification results for related compounds.

Distribution pattern

Nationwide in the USA.

Code information

Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0661-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0661-2020. Report a data issue: hello@regdatalab.com.